New ALSV virus discovered in Swiss ticks
Posted: 9 December 2022 | Izzy Wood (Drug Target Review) | No comments yet
Researchers have detected Alongshan virus (ALSV) for the first time in Switzerland in ticks.
Researchers from the Institute of Virology at the University of Zurich (UZH), Switzerland, have now detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
Ticks can transmit many different pathogens such as viruses, bacteria, and parasites. Of particular concern are the tickborne encephalitis virus (TBEV), which can cause inflammation of the brain and of the linings of the brain and spinal cord, and bacteria leading to the infectious Lyme disease (borreliosis).
The ALSV virus, first discovered in China in 2017, is a member of the flavivirus family along with TBEV.
After being bitten by ticks, several patients suffered from fever and headaches – the typical symptoms of a TBEV infection. Yet, no antibodies against the TBEV virus or its genetic material could be detected in the affected individuals.
Instead, the researchers found a previously unknown RNA virus, the ALSV.
The complete gene sequence of ALSV viruses was found in numerous tick samples collected in several regions of Switzerland in 2021 and 2022.
“Surprisingly, ALS viruses were detected in the tick samples far more frequently than TBEV viruses,” said Cornel Fraefel, director of the Institute of Virology.
Since the symptoms of an infection with ALSV are similar to those of an infection with TBE viruses, the Alongshan virus could already pose a public health concern in Switzerland, albeit hitherto unrecognized.
Unlike for the TBE virus, there are currently no vaccination or serological detection methods for the ALS virus.
Monkeypox mutations cause virus to spread rapidly, evade drugs and vaccines
“Now that we have identified the new virus and published the complete viral genome sequence, our team is developing a serological test to detect ALSV virus infections in patients’ blood samples,” Fraefel concluded.
In collaboration with the national reference laboratory for tickborne diseases and the Spiez laboratory, the researchers plan to investigate the epidemiological spread of ALSV viruses in Switzerland next year.
Related topics
Drug Development, public safety, Targets, Vaccine
Related conditions
Alongshan virus (ALSV), tickborne encephalitis virus (TBEV)
Related organisations
Institute of Virology at the University of Zurich
Related people
Cornel Fraefel